中国视网膜中央动脉阻塞临床诊疗专家共识

doi:10.3969/j.issn.1673-5765.2024.11.002

摘要/Abstract

摘要： 视网膜中央动脉阻塞（central retinal artery occlusion，CRAO）是一种血管神经眼科急症，发病后可导致患者单眼视力急骤下降甚至丧失，显著增加急性缺血性血管事件（如卒中、急性心肌梗死）、死亡和眼部新生血管等发生风险。CRAO被视为急性缺血性卒中的一种特殊类型，临床诊疗仍存在争议，尤其是不同专业背景的医师对CRAO的临床诊疗存在显著差异。因此，制定并推行符合我国国情的CRAO临床诊疗共识显得尤为迫切和必要。我们通过参考国际CRAO管理说明和实践模式，进行系统性文献检索，结合我国国情，制定了《中国视网膜中央动脉阻塞临床诊疗专家共识》（以下简称共识）初稿。经过核心专家组多次审议修订后，最终形成此共识。本共识围绕CRAO的流行病学、解剖及发病机制、危险因素、临床表现、辅助检查、分型、自然病程、视力恢复影响因素、首诊科室、快速评估、治疗（包括保守治疗、对因治疗、静脉溶栓和动脉内溶栓）、血管事件风险（包括急性缺血性血管事件、死亡）、继发眼部新生血管风险与治疗、二级预防和科学管理等方面进行详细且全面的阐述，旨在提高我国CRAO的整体管理水平。临床医师应用此共识时，建议根据患者的实际病情和诊疗中心的具体情况进行个体化诊疗。所有医疗人员要始终坚持“时间就是视觉”理念，尽快将CRAO患者转诊至就近的、具有CRAO诊疗能力的综合卒中中心进行诊治，争取最大限度地改善患者视力，减少并发症发生风险。

关键词: 视网膜中央动脉阻塞; 临床诊疗; 专家共识

Abstract: Central retinal artery occlusion (CRAO) is a vascular neuro-ophthalmic emergency that causes a rapid decline or even loss of vision in one eye after onset. It also significantly increases the risk of acute ischemic vascular events (such as stroke, and acute myocardial infarction), death, and ocular neovascularization (ONV). CRAO is regarded as a special type of acute ischemic stroke, and there are still controversies in its clinical diagnosis and treatment, especially significant differences among physicians with different professional backgrounds. Therefore, it is particularly urgent and necessary to formulate and implement the consensus on the clinical diagnosis and treatment of CRAO that aligns with China’s national circumstances. By referring to international guidelines for CRAO management and practice patterns, conducting systematic literature searches, and combining with China’s national circumstances, we formulated the draft of the Expert Consensus on Clinical Diagnosis and Treatment of Central Retinal Artery Occlusion in China (hereinafter referred to as the consensus). After the core expert group deliberated and revised many times, this consensus was finally formed. This consensus provides a detailed and comprehensive explanation of CRAO’s epidemiology, anatomy and pathogenesis, risk factors, clinical manifestations, auxiliary examinations, classification, the natural course of the disease, factors affecting vision recovery, first contact departments, rapid assessment, treatment (including conservative treatment, etiological treatment, intravenous thrombolysis, and intra-arterial thrombolysis), risk of vascular events (including acute ischemic vascular events and death), risk and treatment of secondary ONV, secondary prevention and scientific management, in order to improve the overall management level of CRAO in our country. When clinicians apply this consensus, it is recommended to provide individualized diagnosis and treatment based on the actual condition of the patient and the specific circumstances of the clinic. All medical staff should always adhere to the concept that “time is vision” and refer CRAO patients to the nearest comprehensive stroke center with CRAO diagnosis and treatment capabilities as soon as possible, striving to maximize the improvement of patients’ vision and reduce the risk of complications.

Key words: Central retinal artery occlusion; Clinical diagnosis and treatment; Expert consensus

中图分类号:

中国研究型医院学会神经眼科专业委员会, 陕西省研究型医院学会神经眼科专业委员会. 中国视网膜中央动脉阻塞临床诊疗专家共识[J]. 中国卒中杂志, 2024, 19(11): 1247-1267.

Neuro-Ophthalmology Society, Chinese Research Hospital Association, Neuro-Ophthalmology Society, Shaanxi Research Hospital Association. Expert Consensus on Clinical Diagnosis and Treatment of Central Retinal Artery Occlusion in China[J]. Chinese Journal of Stroke, 2024, 19(11): 1247-1267.

参考文献

[1] MAC GRORY B，SCHRAG M，BIOUSSE V，et al. Management of central retinal artery occlusion：a scientific statement from the American Heart Association[J/OL]. Stroke，2021，52（6）：e282-e294[2024-10-10]. https://doi.org/10.1161/STR.0000000000000366.
[2] DUMITRASCU O M，NEWMAN N J，BIOUSSE V. Thrombolysis for central retinal artery occlusion in 2020：time is vision！[J]. J Neuroophthalmol，2020，40（3）：333-345.
[3] BIOUSSE V，NAHAB F，NEWMAN N J. Management of acute retinal ischemia：follow the guidelines！[J]. Ophthalmology，2018，125（10）：1597-1607.
[4] 逯青丽，吴松笛. 视网膜动脉阻塞：“视网膜卒中”的认识与挑战[J]. 中国卒中杂志，2023，18（6）：712-719.
LU Q L，WU S D. Retinal artery occlusion：knowledge and challenge of “retinal stroke”[J]. Chin J Stroke，2023，18（6）：712-719.
[5] 魏世辉，宋宏鲁. 我国神经眼科的十年回顾与展望[J]. 中华眼底病杂志，2020，36（4）：253-256.
WEI S H，SONG H L. The review and prospect of the decade of neuro-ophthalmology in China[J]. Chin J Ocul Fundus Dis，2020，36（4）：253-256.
[6] 杨柳，瞿远珍. 我国神经眼科专科医师培养及学科发展现状浅述[J]. 中国卒中杂志，2019，14（6）：630-632.
YANG L，QU Y Z. Neuro-ophthalmologists training and discipline development status[J]. Chin J Stroke，2019，14（6）：630-632.
[7] FLAXEL C J，ADELMAN R A，BAILEY S T，et al. Retinal and ophthalmic artery occlusions preferred practice pattern®[J]. Ophthalmology，2020，127（2）：259-287.
[8] PARK S J，CHOI N K，SEO K H，et al. Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea，2008 to 2011[J]. Ophthalmology，2014，121（10）：1933-1938.
[9] LEAVITT J A，LARSON T A，HODGE D O，et al. The incidence of central retinal artery occlusion in Olmsted County，Minnesota[J]. Am J Ophthalmol，2011，152（5）：820-823.
[10] KIDO A，TAMURA H，IKEDA H O，et al. Nationwide incidence of central retinal artery occlusion in Japan：an exploratory descriptive study using the national database of health insurance claims（2011—2015）[J/OL]. BMJ Open，2020，10（9）：e041104[2024-10-10]. https://doi.org/10.1136/bmjopen-2020-041104.
[11] PICK J，NICKELS S，SAALMANN F，et al. Incidence of retinal artery occlusion in Germany[J/OL]. Acta Ophthalmol，2020，98（5）：e656-e657[2024-10-10]. https://doi.org/10.1111/aos.14369.
[12] LI Y J，HALL N E，PERSHING S，et al. Age，gender，and laterality of retinal vascular occlusion：a retrospective study from the IRIS® registry[J]. Ophthalmol Retina，2022，6（2）：161-171.
[13] BONASIA S，BOJANOWSKI M，ROBERT T. Embryology and anatomical variations of the ophthalmic artery[J]. Neuroradiology，2020，62（2）：139-152.
[14] TIWARI V，BAGGA S S J，PRASAD R，et al. A review of current literature on central retinal artery occlusion：its pathogenesis，clinical management，and treatment[J/OL]. Cureus，2024，16（3）：e55814[2024-10-11]. https://doi.org/10.7759/cureus.55814.
[15] MAC GRORY B，LAVIN P，KIRSHNER H，et al. Thrombolytic therapy for acute central retinal artery occlusion[J]. Stroke，2020，51（2）：687-695.
[16] WANGSA-WIRAWAN N D，LINSENMEIER R A. Retinal oxygen：fundamental and clinical aspects[J]. Arch Ophthalmol，2003，121（4）：547-557.
[17] HAYREH S S，WEINGEIST T A. Experimental occlusion of the central artery of the retina. Ⅰ. Ophthalmoscopic and fluorescein fundus angiographic studies[J]. Br J Ophthalmol，1980，64（12）：896-912.
[18] HAYREH S S，WEINGEIST T A. Experimental occlusion of the central artery of the retina. Ⅳ：retinal tolerance time to acute ischaemia[J]. Br J Ophthalmol，1980，64（11）：818-825.
[19] HAYREH S S，ZIMMERMAN M B，KIMURA A，et al. Central retinal artery occlusion. Retinal survival time[J]. Exp Eye Res，2004，78（3）：723-736.
[20] SCHUMACHER M，SCHMIDT D，JURKLIES B，et al. Central retinal artery occlusion：local intra-arterial fibrinolysis versus conservative treatment，a multicenter randomized trial[J]. Ophthalmology，2010，117（7）：1367-1375.
[21] 逯青丽，刘仲仲，王静，等. 视网膜中央动脉阻塞患者血管神经眼科特征[J]. 中华眼底病杂志，2021，37（10）：775-779.
LU Q L，LIU Z Z，WANG J，et al. Clinical characteristics of vascular neuro-ophthalmology in patients with central retinal artery occlusion[J]. Chin J Ocul Fundus Dis，2021，37（10）：775-779.
[22] LIU T，LU Q L，LIU Z Z，et al. Causal association of type 2 diabetes with central retinal artery occlusion：a Mendelian randomization study[J/OL]. Front Endocrinol（Lausanne），2024，15：1379549[2024-10-11]. https://doi.org/10.3389/fendo.2024.1379549.
[23] CALLIZO J，FELTGEN N，PANTENBURG S，et al. Cardiovascular risk factors in central retinal artery occlusion：results of a prospective and standardized medical examination[J]. Ophthalmology，2015，122（9）：1881-1888.
[24] LEE K E，TSCHOE C，COFFMAN S A，et al. Management of acute central retinal artery occlusion，a “retinal stroke”：an institutional series and literature review[J/OL]. J Stroke Cerebrovasc Dis，2021，30（2）：105531[2024-10-11]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105531.
[25] LU Q L，HAN X N，LIU P，et al. Central retinal artery occlusion caused by radiation-induced carotid stenosis[J]. Acta Neurol Belg，2024，124（1）：371-373.
[26] LEE J S，KIM J Y，JUNG C，et al. Iatrogenic ophthalmic artery occlusion and retinal artery occlusion[J/OL]. Prog Retin Eye Res，2020：100848[2024-10-11]. https://doi.org/10.1016/j.preteyeres.2020.100848.
[27] CHO K H，AHN S J，CHO J H，et al. The characteristics of retinal emboli and its association with vascular reperfusion in retinal artery occlusion[J]. Invest Ophthalmol Vis Sci，2016，57（11）：4589-4598.
[28] MEHTA N，MARCO R D，GOLDHARDT R，et al. Central retinal artery occlusion：acute management and treatment[J]. Curr Ophthalmol Rep，2017，5（2）：149-159.
[29] LITTLEWOOD R，MOLLAN S P，PEPPER I M，et al. The utility of fundus fluorescein angiography in neuro-ophthalmology[J]. Neuroophthalmology，2019，43（4）：217-234.
[30] 王润生，吕沛霖，王宾，等. 视网膜中央动脉阻塞患者视网膜循环时间与中心视力损害的关系[J]. 中华眼底病杂志，2007，23（3）：177-179.
WANG R S，LYU P L，WANG B，et al. Relationship between retinal circulation time and visual loss in patients with central retinal artery occlusion[J]. Chin J Ocul Fundus Dis，2007，23（3）：177-179.
[31] AHN S J，PARK K H，RYOO N K，et al. No-reflow phenomenon in central retinal artery occlusion：incidence，risk factors，and clinical implications[J/OL]. PLoS One，2015，10（11）：e0142852[2024-10-11]. https://doi.org/10.1371/journal.pone.0142852.
[32] JUNG Y H，AHN S J，HONG J H，et al. Incidence and clinical features of neovascularization of the iris following acute central retinal artery occlusion[J]. Korean J Ophthalmol，2016，30（5）：352-359.
[33] WENZEL D A，KROMER R，POLI S，et al. Optical coherence tomography-based determination of ischaemia onset—the temporal dynamics of retinal thickness increase in acute central retinal artery occlusion[J/OL]. Acta Ophthalmol，2021，99（2）：e247-e252[2024-10-11]. https://doi.org/10.1111/aos.14563.
[34] AHN S J，WOO S J，PARK K H，et al. Retinal and choroidal changes and visual outcome in central retinal artery occlusion：an optical coherence tomography study[J]. Am J Ophthalmol，2015，159（4）：667-676.
[35] DOTAN G，GOLDENBERG D，KESLER A，et al. The use of spectral-domain optical coherence tomography for differentiating long-standing central retinal artery occlusion and nonarteritic anterior ischemic optic neuropathy[J]. Ophthalmic Surg Lasers Imaging Retina，2014，45（1）：38-44.
[36] 《人工智能在OCTA图像分析和眼部疾病诊断中的应用指南（2024）》专家组，国际转化医学会眼科专业委员会，中国医药教育协会眼科影像与智能医疗分会. 人工智能在OCTA图像分析和眼部疾病诊断中的应用指南（2024）[J]. 眼科新进展，2024，44（5）：337-345.
Expert Group of Guidelines for the Use of Artificial Intelligence in OCTA Image Analysis and Diagnosis of Ocular Diseases（2024），Ophthalmology Professional Committee of International Society of Translational Medicine，Ophthalmic Imaging and Intelligent Medicine Branch of China Medicine Education Association. Guidelines for the use of artificial intelligence in OCTA image analysis and diagnosis of ocular diseases（2024）[J]. Rec Adv Ophthalmol，2024，44（5）：337-345.
[37] BONINI FILHO M A，ADHI M，DE CARLO T E，et al. Optical coherence tomography angiography in retinal artery occlusion[J]. Retina，2015，35（11）：2339-2346.
[38] YANG S，LIU X Q，LI H，et al. Optical coherence tomography angiography characteristics of acute retinal arterial occlusion[J/OL]. BMC Ophthalmol，2019，19（1）：147[2024-10-11]. https://doi.org/10.1186/s12886-019-1152-8.
[39] HELENIUS J，ARSAVA E M，GOLDSTEIN J N，et al. Concurrent acute brain infarcts in patients with monocular visual loss[J]. Ann Neurol，2012，72（2）：286-293.
[40] LEE J，KIM S W，LEE S C，et al. Co-occurrence of acute retinal artery occlusion and acute ischemic stroke：diffusion-weighted magnetic resonance imaging study[J]. Am J Ophthalmol，2014，157（6）：1231-1238.
[41] LAUDA F，NEUGEBAUER H，REIBER L，et al. Acute silent brain infarction in monocular visual loss of ischemic origin[J]. Cerebrovasc Dis，2015，40（3/4）：151-156.
[42] CHODNICKI K D，PULIDO J S，HODGE D O，et al. Stroke risk before and after central retinal artery occlusion in a US cohort[J]. Mayo Clin Proc，2019，94（2）：236-241.
[43] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国急性缺血性卒中诊治指南2023[J]. 中华神经科杂志，2024，57（6）：523-559.
Chinese Society of Neurology，Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023[J]. Chin J Neurol，2024，57（6）：523-559.
[44] HAYREH S S，PODHAJSKY P A，ZIMMERMAN M B. Retinal artery occlusion：associated systemic and ophthalmic abnormalities[J]. Ophthalmology，2009，116（10）：1928-1936.
[45] LAVIN P，PATRYLO M，HOLLAR M，et al. Stroke risk and risk factors in patients with central retinal artery occlusion[J/OL]. Am J Ophthalmol，2018，196：96-100[2024-10-11]. https://doi.org/10.1016/j.ajo.2018.08.027.
[46] KIM J，JUNG S，PARK K H，et al. Cerebral angiographic features of central retinal artery occlusion patients treated with intra-arterial thrombolysis[J]. J Neurointerv Surg，2022，14（8）：772-778.
[47] CHEN C，SINGH G，MADIKE R，et al. Central retinal artery occlusion：a stroke of the eye[J]. Eye（Lond），2024，38（12）：2319-2326.
[48] JUSTICE J，Jr，LEHMANN R P. Cilioretinal arteries. A study based on review of stereo fundus photographs and fluorescein angiographic findings[J]. Arch Ophthalmol，1976，94（8）：1355-1358.
[49] HAYREH S S，ZIMMERMAN M B. Central retinal artery occlusion：visual outcome[J]. Am J Ophthalmol，2005，140（3）：376-391.
[50] MATTHE E，EULITZ P，FURASHOVA O. Acute retinal ischemia in central versus branch retinal artery occlusion：changes in retinal layers’ thickness on spectral-domain optical coherence tomography in different grades of retinal ischemia[J]. Retina，2020，40（6）：1118-1123.
[51] FURASHOVA O，MATTHÉ E. Retinal changes in different grades of retinal artery occlusion：an optical coherence tomography study[J]. Invest Ophthalmol Vis Sci，2017，58（12）：5209-5216.
[52] SCHRAG M，YOUN T，SCHINDLER J，et al. Intravenous fibrinolytic therapy in central retinal artery occlusion：a patient-level meta-analysis[J]. JAMA Neurol，2015，72（10）：1148-1154.
[53] HAYREH S S. Ocular vascular occlusive disorders：natural history of visual outcome[J/OL]. Prog Retin Eye Res，2014，41：1-25[2024-10-11]. https://doi.org/10.1016/j.preteyeres.2014.04.001.
[54] 吕沛霖，王润生，杜善双. 视网膜中央动脉阻塞患眼睫状视网膜动脉存在情况及其与中心视力损害的关系[J]. 中华眼底病杂志，2014，30（5）：454-457.
LYU P L，WANG R S，DU S S. Correlation between cilioretinal artery and central visual loss in central retinal artery occlusion[J]. Chin J Ocul Fundus Dis，2014，30（5）：454-457.
[55] KANG D W，JUNG K H，YANG W，et al. Presence of embolic source and outcome in central retinal artery occlusion[J/OL]. Neurology，2023，101（13）：e1364-e1369[2024-10-11]. https://doi.org/10.1212/WNL.0000000000207445.
[56] YOUN T S，LAVIN P，PATRYLO M，et al. Current treatment of central retinal artery occlusion：a national survey[J]. J Neurol，2018，265（2）：330-335.
[57] HOYER C，KAHLERT C，GÜNEY R，et al. Central retinal artery occlusion as a neuro-ophthalmological emergency：the need to raise public awareness[J]. Eur J Neurol，2021，28（6）：2111-2114.
[58] 石慧君，赵晓丽，张铭连，等. 中西医结合药物联合星状神经节阻滞治疗视网膜中央动脉阻塞的临床疗效观察[J]. 中国中医眼科杂志，2018，28（6）：389-393.
SHI H J，ZHAO X L，ZHANG M L，et al. Clinical observation on treatment of central retinal artery occlusion by integrated traditional Chinese and western medicine combined with stellate ganglion block[J]. China Journal of Chinese Ophthalmology，2018，28（6）：389-393.
[59] 雷涛，王润生，张博，等. 尿激酶动脉溶栓对非动脉炎性视网膜中央动脉阻塞患者的疗效和安全性[J]. 眼科新进展，2023，43（3）：198-202.
LEI T，WANG R S，ZHANG B，et al. Efficacy and safety of urokinase in arterial thrombolytic therapy of non-ar-teritic central retinal artery occlusion[J]. Rec Adv Ophthalmol，2023，43（3）：198-202.
[60] GAO Y，ZHAO W B，WU D，et al. Intra-arterial thrombolysis for acute retinal ischemia：a retrospective，observational，cohort study[J]. J Neuroophthalmol，2023，43（2）：202-208.
[61] 逯青丽，刘仲仲，刘彤，等. 动脉内溶栓治疗视网膜中央动脉阻塞患者的临床特征及功能性视觉恢复单中心研究[J]. 中国卒中杂志，2024，19（3）：273-279.
LU Q L，LIU Z Z，LIU T，et al. Clinical features and functional visual recovery of patients with central retinal artery occlusion treated with intra-arterial thrombolysis：a single-center study[J]. Chin J Stroke，2024，19（3）：273-279.
[62] 中华医学会眼科学分会神经眼科学组，中国医药教育协会眼科专业委员会，复方樟柳碱临床应用专家共识专家组. 复方樟柳碱注射液在常见缺血性眼病中应用专家共识（2020版）[J]. 中华实验眼科杂志，2020，38（7）：553-561.
Neuroophthalmology Group，Society of Ophthalmology of Chinese Medical Association, Ophthalmology Committee of China Medical Education Association, Experts Consensus Group of Compound Anisodine Injection Application. Chinese experts consensus on compound anisodine injection in the ischemic ophthalmopathy clinical practice（2020）[J]. Chin J Exp Ophthalmol，2020，38（7）：553-561.
[63] DATTILO M，BIOUSSE V，NEWMAN N J. Update on the management of central retinal artery occlusion[J]. Neurol Clin，2017，35（1）：83-100.
[64] RUMELT S，DORENBOIM Y，REHANY U. Aggressive systematic treatment for central retinal artery occlusion[J]. Am J Ophthalmol，1999，128（6）：733-738.
[65] BORG F A，SALTER V L J，DASGUPTA B. Neuro-ophthalmic complications in giant cell arteritis[J]. Curr Allergy Asthma Rep，2008，8（4）：323-330.
[66] 王培，冯学兵，段兴旺，等. 风湿性多肌痛和巨细胞动脉炎的诊疗规范[J]. 中华内科杂志，2023，62（3）：256-266.
WANG P，FENG X B，DUAN X W，et al. Recommendations of diagnosis and treatment of giant cell arteritis and polymyalgia rheumatic in China[J]. Chin J Intern Med，2023，62（3）：256-266.
[67] HUMZAH M D，ATAULLAH S，CHIANG C，et al. The treatment of hyaluronic acid aesthetic interventional induced visual loss（AIIVL）：a consensus on practical guidance[J]. J Cosmet Dermatol，2019，18（1）：71-76.
[68] GOODMAN G J，MAGNUSSON M R，CALLAN P，et al. A consensus on minimizing the risk of hyaluronic acid embolic visual loss and suggestions for immediate bedside management[J]. Aesthet Surg J，2020，40（9）：1009-1021.
[69] 王润生，吕沛霖，张娅萍，等. 以尿激酶静脉溶栓为主治疗视网膜中央动脉阻塞115例临床疗效观察[J]. 中华眼底病杂志，2012，28（5）：466-471.
WANG R S，LYU P L，ZHANG Y P，et al. Intravenous thrombolysis with urokinase for central retinal artery occlusion in 115 patients[J]. Chin J Ocul Fundus Dis，2012，28（5）：466-471.
[70] MAC GRORY B，NACKENOFF A，POLI S，et al. Intravenous fibrinolysis for central retinal artery occlusion：a cohort study and updated patient-level meta-analysis[J]. Stroke，2020，51（7）：2018-2025.
[71] POLI S，GROHMANN C，WENZEL D A，et al. Early reperfusion therapy with intravenous alteplase for recovery of vision in acute central retinal artery occlusion（REVISION）：study protocol of a phase Ⅲ trial[J]. Int J Stroke，2024，19（7）：823-829.
[72] WANG R S，QIAN L，WANG Y，et al. Evaluation of ophthalmic artery branch retrograde intervention in the treatment of central retinal artery occlusion（CRAO）[J/OL]. Med Sci Monit，2017，23：114-120[2024-10-11]. https://doi.org/10.12659/msm.898352.
[73] BEATTY S，AU EONG K G. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery：a meta-analysis of the published data[J]. Br J Ophthalmol，2000，84（8）：914-916.
[74] SCHMIDT D P，SCHULTE-MÖNTING J，SCHUMACHER M. Prognosis of central retinal artery occlusion：local intraarterial fibrinolysis versus conservative treatment[J]. AJNR Am J Neuroradiol，2002，23（8）：1301-1307.
[75] PIELEN A，PANTENBURG S，SCHMOOR C，et al. Predictors of prognosis and treatment outcome in central retinal artery occlusion：local intra-arterial fibrinolysis vs. conservative treatment[J]. Neuroradiology，2015，57（10）：1055-1062.
[76] PAGE P S，KHATTAR N K，WHITE A C，et al. Intra-arterial thrombolysis for acute central retinal artery occlusion：a systematic review and meta-analysis[J/OL]. Front Neurol，2018，9：76[2024-10-11]. https://doi.org/10.3389/fneur.2018.00076.
[77] HU H T，ZHANG B，ZHAO Y Q，et al. Efficacy of intra-arterial thrombolysis for acute central retinal artery occlusion：a meta-analysis[J]. Eur Neurol，2022，85（3）：186-194.
[78] 雷涛，王润生，张博，等. 不同时间窗尿激酶动脉溶栓治疗视网膜中央动脉阻塞的疗效对比观察[J]. 中华眼底病杂志，2020，36（10）：788-794.
LEI T，WANG R S，ZHANG B，et al. Comparative analysis of urokinase arterial thrombolytic therapy for central retinal artery occlusion in different time window[J]. Chin J Ocul Fundus Dis，2020，36（10）：788-794.
[79] KREMER C，GDOVINOVA Z，BEJOT Y，et al. European Stroke Organisation guidelines on stroke in women：management of menopause，pregnancy and postpartum[J/OL]. Eur Stroke J，2022，7（2）：Ⅰ-ⅩⅨ[2024-10-11]. https://doi.org/10.1177/23969873221078696.
[80] ALBERS G W，JUMAA M，PURDON B，et al. Tenecteplase for stroke at 4.5 to 24 hours with perfusion-imaging selection[J]. N Engl J Med，2024，390（8）：701-711.
[81] KERNAN W N，OVBIAGELE B，BLACK H R，et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke，2014，45（7）：2160-2236.
[82] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国缺血性卒中和短暂性脑缺血发作二级预防指南2022[J]. 中华神经科杂志，2022，55（10）：1071-1110.
Chinese Society of Neurology，Chinese Stroke Society. Chinese guideline for the secondary prevention of ischemic stroke and transient ischemic attack 2022[J]. Chin J Neurol，2022，55（10）：1071-1110.
[83] CHEN Y C，WU H M，CHEN S J，et al. Intra-arterial thrombolytic therapy is not a therapeutic option for filler-related central retinal artery occlusion[J]. Facial Plast Surg，2018，34（3）：325-329.
[84] MIR T A，ARHAM A Z，FANG W，et al. Acute vascular ischemic events in patients with central retinal artery occlusion in the United States：a nationwide study 2003—2014[J/OL]. Am J Ophthalmol，2019，200：179-186[2024-10-11]. https://doi.org/10.1016/j.ajo.2019.01.009.
[85] PARK S J，CHOI N K，YANG B R，et al. Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion[J]. Ophthalmology，2015，122（11）：2336-2343.
[86] WANG J J，CUGATI S，KNUDTSON M D，et al. Retinal arteriolar emboli and long-term mortality：pooled data analysis from two older populations[J]. Stroke，2006，37（7）：1833-1836.
[87] ROSKAL-WAŁEK J，WAŁEK P，BISKUP M，et al. Central and branch retinal artery occlusion—do they harbor the same risk of further ischemic events？[J/OL]. J Clin Med，2021，10（14）：3093[2024-10-11].
https://doi.org/10.3390/jcm10143093.
[88] HWANG D D，LEE K E，KIM Y，et al. Incidence of retinal artery occlusion and related mortality in Korea，2005 to 2018[J/OL]. JAMA Netw Open，2023，6（3）：e233068[2024-10-11]. https://doi.org/10.1001/jamanetworkopen.2023.3068.
[89] MASON J O，3rd，PATEL S A，FEIST R M，et al. Ocular neovascularization in eyes with a central retinal artery occlusion or a branch retinal artery occlusion[J/OL]. Clin Ophthalmol，2015，9：995-1000[2024-10-11]. https://doi.org/10.2147/OPTH.S82796.
[90] HAYREH S S. Prevalent misconceptions about acute retinal vascular occlusive disorders[J]. Prog Retin Eye Res，2005，24（4）：493-519.
[91] RUDKIN A K，LEE A W，CHEN C S. Ocular neovascularization following central retinal artery occlusion：prevalence and timing of onset[J]. Eur J Ophthalmol，2010，20（6）：1042-1046.
[92] CHAWLA H，REDRICK H J，PANNELL J T，et al. Incidence of total blindness after central retinal artery occlusion with ocular neovascularization[J]. J Vitreoretin Dis，2024，8（1）：75-81.
[93] LUSK J B，SONG A，UNNITHAN S，et al. Association between hospital-documented atrial fibrillation and central retinal artery occlusion[J]. Stroke，2023，54（4）：983-991.
[94] GAGE B F，WATERMAN A D，SHANNON W，et al. Validation of clinical classification schemes for predicting stroke：results from the national registry of atrial fibrillation[J]. JAMA，2001，285（22）：2864-2870.
[95] FLOWERS A M，CHAN W，MEYER B I，et al. Referral patterns of central retinal artery occlusion to an academic center affiliated with a stroke center[J]. J Neuroophthalmol，2021，41（4）：480-487.
[96] CHAN W，FLOWERS A M，MEYER B I，et al. Acute central retinal artery occlusion seen within 24 hours at a tertiary institution[J/OL]. J Stroke Cerebrovasc Dis，2021，30（9）：105988[2024-10-11]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105988.
[97] AROOR S，SINGH R，GOLDSTEIN L B. BE-FAST（balance，eyes，face，arm，speech，time）：reducing the proportion of strokes missed using the FAST mnemonic[J]. Stroke，2017，48（2）：479-481.
[98] 吴松笛. 关注血管神经眼科疾病——概念、诊疗方法及策略[J]. 中国卒中杂志，2024，19（3）：245-254.
WU S D. Focus on vascular neuro-ophthalmic diseases：concepts，diagnostic methods，and treatment strategies[J]. Chin J Stroke，2024，19（3）：245-254.
[99] ALBERTS M J，WECHSLER L R，JENSEN M E，et al. Formation and function of acute stroke-ready hospitals within a stroke system of care recommendations from the brain attack coalition[J]. Stroke，2013，44（12）：3382-3393.